Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2016 Results Presentation and Webcast
Oslo, Norway, 22 February 2017 Nordic Nanovector ASA (OSE: NANO), a biopharmaceutical company focusing on the development and commercialisation of novel targeted therapeutics for haematological cancers, will announce its fourth quarter and full year 2016 results on Tuesday, 28th of February 2017. A presentation by Nordic Nanovector’s senior management team will take place at 8:30 am CET at: Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 OsloMeeting Room: NYLAND The presentation will be recorded as a webcast and will be available at www.nordicnanovector.com in the section: